Jason Kang, Katherine Jin and Kevin Tyan

Columbia University
Highlight: A Powdered Additive for Disinfectants
Undergraduate Team Winner

Jason Kang, Katherine Jin and Kevin Tyan are undergraduate students in their senior year at Columbia University who came together to form their startup, Kinnos Inc., with the shared desire to work on an invention that makes a significant societal impact.

Jason Kang, of North Andover, Mass., is studying biomedical engineering at Columbia’s School of Engineering and brings years of research experience to the team, having spent time in laboratories at Harvard Medical School/Massachusetts General Hospital and Columbia University. Jason mentors first-year college students, is a teaching assistant at Columbia, and served as Philanthropy Chair of his fraternity. Jason is also the VP of Engineering at Jibon Health Technologies and invented a device to treat postpartum hemorrhage, which is undergoing clinical trials in Bangladesh.

Katherine Jin, of Belle Mead, N.J., is studying biology and computer science and has a passion for research; she has extensive research experience in various laboratories at Columbia University, the Carnegie Institute, and Mount Sinai St. Luke’s Hospital emergency department. Outside of the lab and classroom, Katherine volunteers at Columbia University Health Leads, a national nonprofit partnering with hospitals that work on behalf of underserved populations. She has also been involved in Youth for Debate, where she taught students in underserved schools how to better advocate for themselves by providing a free afterschool program to learn the principles of debate.

Kevin Tyan, of Bethesda, Md., is a pre-medical student studying biology. He has previously worked at the National Institutes of Health, National Cancer Institute and MedImmune-AstraZeneca on different experimental cancer treatments. His desire to invent something that could save human lives was ignited by his time at the National Cancer Institute, where he helped determine the efficacy of a breast cancer drug in its first in-human clinical trial. Kevin serves on the executive board of the Columbia University Emergency Medical Service, a student-operated, non-profit, New York State-certified ambulance corps, where he works as an EMT to provide care and transportation to patients during medical emergencies. He is also currently a teaching assistant and is passionate about teaching science and interacting with students.